Table 1.
Characteristics of study population
| Characteristics | No of patients | Mean (SD) age at start of orlistat (years) | Unexposed period* | Exposed period | |||
|---|---|---|---|---|---|---|---|
| No of events | Mean (SD) duration of follow-up (years) | No of events | Mean (SD) duration of use (years) | ||||
| Definite and probable cases: | |||||||
| All | 988 | 48.4 (12.8) | 894 | 9.2 (2.7) | 94 | 0.9 (0.9) | |
| Men | 309 | 48.9 (11.8) | 284 | 9.1 (2.8) | 25 | 0.8 (0.8) | |
| Women | 679 | 48.3 (13.3) | 610 | 9.3 (2.7) | 69 | 0.9 (1.0) | |
| Definite cases: | |||||||
| All | 335 | 47.9 (13.1) | 308 | 9.3 (2.5) | 27 | 0.9 (0.9) | |
| Men | 98 | 48.1 (11.1) | 89 | 9.0 (2.4) | 9 | 0.8 (0.7) | |
| Women | 237 | 47.8 (13.9) | 219 | 9.4 (2.6) | 18 | 0.9 (1.0) | |
*Before or after orlistat use.